Adjuvant vs Surgery Only in Early-stage Recurrent NPC
Status:
RECRUITING
Trial end date:
2028-06-30
Target enrollment:
Participant gender:
Summary
Adjuvant Therapy Versus Endoscopic Surgery Alone in Early-stage Recurrent Nasopharyngeal Carcinoma: A Multicenter Randomized Controlled Trial
Phase:
PHASE3
Details
Lead Sponsor:
Eye & ENT Hospital of Fudan University
Collaborators:
Changhai Hospital Fujian Medical University Union Hospital People's Hospital of Guangxi Zhuang Autonomous Region Shanghai 6th People's Hospital Shanghai Zhongshan Hospital Shenzhen Second People's Hospital
Treatments:
Drug Therapy Gemcitabine Immunotherapy toripalimab